Federal Crackdown on Healthcare Fraud: What Providers Need to Know

Late in 2025 and early 2026, federal officials made headlines for an unusually public push to target alleged healthcare fraud in California, invoking prosecutions in Minnesota as part of a broader narrative about government enforcement priorities. At a January 2026 press briefing in Los Angeles, CMS Administrator Dr. Mehmet Oz and First Assistant U.S. Attorney Bill Essayli publicly characterized what they described as large-scale fraud involving hospice care, home health services, and other government-funded healthcare programs. The comments and media coverage that followed have left many professionals in California’s healthcare industry with questions: What is actually happening? How might it affect me? And why does this matter from a defense perspective?

From the vantage point of a California healthcare fraud defense attorney, it’s critical to separate enforcement rhetoric from prosecutorial reality while understanding the serious implications of increased scrutiny. Healthcare providers often underestimate how aggressively the government can pursue billing irregularities, referral arrangements, and program participation issues, or how quickly compliance risk can escalate into criminal exposure. In Los Angeles or statewide, call The Law Offices of Stanley L. Friedman in Beverly Hills for practical advice and effective advocacy from a former Assistant U.S. Attorney experienced in prosecuting and now defending California healthcare providers accused of Medi-Cal fraud or related offenses.

What Federal Officials Said in the Briefing

At the Los Angeles press conference, Dr. Oz and U.S. Attorney Bill Essayli spoke publicly about ongoing efforts to “audit California programs, California systems, California doctors,” signaling an expanded federal focus on alleged fraud within the state’s healthcare infrastructure. Dr. Oz, who leads the Centers for Medicare & Medicaid Services (CMS), singled out hospice and home healthcare billing as areas of concern, suggesting that dramatic increases in certain types of billing require investigation.

Dr. Oz also alleged that patients may not realize they have been enrolled in hospice care or other programs that dramatically change their treatment options, raising questions about consent and proper clinical evaluation.

Mr. Essayli, speaking in a law enforcement role, drew comparisons between what was happening in California and a large fraud scandal in Minnesota, stating that he believed “what’s happening in Minnesota pales in comparison to the level of fraud that we believe is occurring in California.” The Minnesota reference—linked to widely reported allegations of significant Medicaid and social services fraud in that state—served to highlight California as a priority enforcement jurisdiction in the federal government’s view.

While neither official announced specific indictments or named targets at that briefing, the unusual public nature of the remarks drew attention precisely because federal prosecutors typically do not discuss active investigations in detail before charges are filed. That departure from typical prosecutorial silence suggests an evolving environment where compliance risk and potential criminal exposure may attract more visible federal attention.

California Healthcare Fraud Prosecutions Are Evolving

For decades, federal and state authorities have pursued healthcare fraud cases in California. These include investigations into hospice billing, home health services, DME (durable medical equipment) claims, telemedicine prescribing, and many other areas where government programs reimburse providers for services billed to Medi-Cal, Medicare, or federally funded healthcare initiatives.

Traditionally, enforcement actions grow out of years-long data analysis, audits, whistleblower referrals, and interagency cooperation. They often culminate in indictments charging false claims, conspiracy, kickbacks, identity misuse, or controlled substances diversion. Once formal charges are filed, prosecutors typically announce them with detailed press releases outlining the alleged misconduct and expected penalties.

The January 2026 briefing, in contrast, presented enforcement priorities in broad strokes before specific charges were publicly announced. This shift underscores the federal government’s view that healthcare fraud continues to be a high-priority area—so high that officials felt compelled to bring it into the public eye early.

Why This Matters to Healthcare Providers

For licensed providers and organizations in California, the implications are significant:

First, the sheer scale of alleged abuse referenced—billions of dollars in billing across various programs—underscores that authorities are looking at systemic issues, not isolated errors. Scaling alleged fraud to such a magnitude means that even routine billing or documentation discrepancies could draw scrutiny if they fit patterns investigators consider anomalous.

Second, federal and state agents, including the Department of Justice, CMS, FBI, HHS Office of Inspector General, and state attorneys general, coordinate enforcement actions with advanced analytics and shared investigations. Providers who find themselves part of an audit or inquiry are often already part of a multi-agency data-driven investigation that has proceeded far behind the scenes.

Third, leadership statements, even before indictments, can influence enforcement posture and prosecutor emphasis. When top officials publicly frame fraud as a top priority, that can translate into increased audit activity, follow-up investigations, and a willingness to pursue criminal charges rather than civil resolutions.

A Defense Attorney’s Perspective: Why Early Counsel Matters

As a former Assistant U.S. Attorney in the Major Frauds Section of the U.S. Attorney’s Office in Los Angeles who prosecuted healthcare fraud cases and sat in the very offices and conference rooms where current prosecutors now work, California healthcare defense attorney Stanley L. Friedman understands how these investigations unfold from the inside.

Government investigations typically begin with billing data anomalies, audits, data analytics, or whistleblower tips. The government often waits until it believes it has built an airtight case before it files charges. For defendants, the period before charges are filed is the most important time to engage counsel.

Early representation matters because:

• A defense attorney can manage responses to subpoenas or administrative audits and limit exposure.
• A senior litigator familiar with the prosecutors’ strategies can engage early with investigators to shape narratives rather than simply respond to them.

Once charges are filed, especially in large-scale investigations where dollar figures and alleged patterns are prominently cited, defending becomes significantly more difficult.

Qualified Defense Is Essential

The federal push against alleged healthcare fraud in California, as highlighted by the January 2026 press briefing, is a clear reminder that authorities are watching, analyzing, and preparing enforcement actions that can affect providers at any level of care.

For healthcare professionals, billing entities, and clinical providers in Los Angeles and across California, this environment demands a proactive approach to compliance and, when questions arise, the guidance of legal counsel who understands how prosecutors think, how investigations are built, and how defenses can be structured effectively.

Early, qualified representation is not just advocacy after the fact. It can be the critical factor that protects your career, license, and livelihood long before charges ever see the inside of a courtroom.

If you are under investigation or have been charged with Medi-Cal fraud or other healthcare fraud matters in California, contact The Law Offices of Stanley L. Friedman to speak with a California Board-Certified Criminal Law Specialist who specializes in defending people charged with healthcare fraud, financial fraud, and other white-collar criminal offenses.